User profiles for Toni Seppälä

Toni T. Seppälä

University of Tampere
Verified email at tuni.fi
Cited by 5183

Cancer risk and survival in path_MMR carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome Database

P Møller, TT Seppälä, I Bernstein, E Holinski-Feder… - Gut, 2018 - gut.bmj.com
Background Most patients with path_MMR gene variants (Lynch syndrome (LS)) now survive
both their first and subsequent cancers, resulting in a growing number of older patients with …

[HTML][HTML] Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database

M Dominguez-Valentin, JR Sampson, TT Seppälä… - Genetics in …, 2020 - nature.com
Purpose Pathogenic variants affecting MLH1, MSH2, MSH6, and PMS2 cause Lynch syndrome
and result in different but imprecisely known cancer risks. This study aimed to provide …

Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome …

P Møller, T Seppälä, I Bernstein, E Holinski-Feder… - Gut, 2017 - gut.bmj.com
Objective Estimates of cancer risk and the effects of surveillance in Lynch syndrome have
been subject to bias, partly through reliance on retrospective studies. We sought to establish …

[HTML][HTML] Cancer prevention with aspirin in hereditary colorectal cancer (Lynch syndrome), 10-year follow-up and registry-based 20-year data in the CAPP2 study: a …

…, PJ Morrison, J Rashbass, R Ramesar, T Seppälä… - The Lancet, 2020 - thelancet.com
Background Lynch syndrome is associated with an increased risk of colorectal cancer and
with a broader spectrum of cancers, especially endometrial cancer. In 2011, our group …

[HTML][HTML] Genetic and epigenetic characteristics of inflammatory bowel Disease–Associated colorectal cancer

…, N Välimäki, A Kuosmanen, RM Plaketti, TT Seppälä… - Gastroenterology, 2021 - Elsevier
Background & Aims Inflammatory bowel disease (IBD) is a chronic, relapsing inflammatory
disorder associated with an elevated risk of colorectal cancer (CRC). IBD-associated CRC (…

[HTML][HTML] The shared frameshift mutation landscape of microsatellite-unstable cancers suggests immunoediting during tumor evolution

…, M Bonsack, S Schott, H Bläker, T Seppälä… - Nature …, 2020 - nature.com
The immune system can recognize and attack cancer cells, especially those with a high load
of mutation-induced neoantigens. Such neoantigens are abundant in DNA mismatch repair …

Incidence of and survival after subsequent cancers in carriers of pathogenic MMR variants with previous cancer: a report from the prospective Lynch syndrome …

P Møller, T Seppälä, I Bernstein, E Holinski-Feder… - Gut, 2017 - gut.bmj.com
Objective Today most patients with Lynch syndrome (LS) survive their first cancer. There is
limited information on the incidences and outcome of subsequent cancers. The present study …

No difference in colorectal cancer incidence or stage at detection by colonoscopy among 3 countries with different Lynch syndrome surveillance policies

C Engel, HF Vasen, T Seppälä, S Aretz… - Gastroenterology, 2018 - Elsevier
Background & Aims Patients with Lynch syndrome are at high risk for developing colorectal
cancer (CRC). Regular colonoscopic surveillance is recommended, but there is no …

[HTML][HTML] Cerebrospinal fluid biomarker and brain biopsy findings in idiopathic normal pressure hydrocephalus

…, M Lumela, J Rummukainen, O Nerg, TT Seppälä… - PloS one, 2014 - journals.plos.org
Background The significance of amyloid precursor protein (APP) and neuroinflammation in
idiopathic normal pressure hydrocephalus (iNPH) and Alzheimer's disease (AD) is unknown. …

[HTML][HTML] Spatially resolved multimarker evaluation of CD274 (PD-L1)/PDCD1 (PD-1) immune checkpoint expression and macrophage polarisation in colorectal cancer

…, MC Lau, O Helminen, EV Wirta, TT Seppälä… - British Journal of …, 2023 - nature.com
Background The CD274 (PD-L1)/PDCD1 (PD-1) immune checkpoint interaction may promote
cancer progression, but the expression patterns and prognostic significance of PD-L1 and …